The Hill published an op-ed by Einstein's Dean, Allen M. Spiegel, M.D., and Montefiore President and CEO Steven Safyer, M.D., titled "Angelina Jolie, the Sequester, and Health in America." The authors argue that Ms. Jolie's decision to undergo a prophylactic mastectomy was made possible by two decades of research by inquisitive scientists on the BRCA1 and BRCA2 genes, much of it supported by the NIH. They assert that the funding cuts demanded by the sequester places this type of research in jeopardy.

Dean Allen M. Spiegel, M.D., explains the power of technology to improve clinical care and its importance in medical education on The Stoler Report.. Dr. Spiegel, who was joined by deans from the Icahn School of Medicine at Mt. Sinai, Hofstra-LIJ and New York Medical College, noted that technology can be harnessed to support preventive care but that medical students must be taught the importance of personal interaction with patients. Dr. Spiegel is the Marilyn and Stanley M. Katz Dean at Einstein.

New York Times interviews Dean Allen M. Spiegel, M.D., as part of a profile on Steven M. Safyer, M.D., the president of Montefiore Medical Center and an Einstein alumnus. Dr. Spiegel noted that Montefiore’s combination of high quality care and community responsibility is unique. Dr. Spiegel is the Marilyn and Stanley M. Katz Dean at Einstein.

Associated Press features comments by Dean Allen M. Spiegel, M.D., about Einstein’s progress in stem cell research since state funding began in 2007. The report on the Empire State Stem Cell Program notes that Einstein has advanced the understanding of blood stem cell function and of liver cell replication which could help make liver transplantation easier. Dr. Spiegel is the Marilyn and Stanley M. Katz Dean at Einstein.

The New York Daily News interviews Dean Allen M. Spiegel, M.D., about the Van Etten renovations that are transforming the building into a state-of-the-art facility for education, research and medical care. Dr. Spiegel is the Marilyn and Stanley M. Katz Dean at Einstein.

MedPage Today features Dean Allen M. Spiegel’s participation on a panel of prominent medical school deans who discussed the usefulness and flaws of U.S. News & World Report’s annual medical school rankings. Dr. Spiegel noted that among the problems is the low response rate from residency program directors – less than 20 percent – which undercuts the reliability of the results. Dr. Spiegel is the Marilyn and Stanley M. Katz Dean at Einstein.

More coverage on this story

The Chronicle of Higher Education (paid subscription required)
NPR's Shots Blog
Kaiser Health News

Dan's Papers highlights a panel led by Allen M. Spiegel, M.D., the Marilyn and Stanley Katz Dean of Einstein, which featured Einstein faculty members discussing research breakthroughs and trends in medical care. Presenting members of the faculty included: John Condeelis, Ph.D., the Judith and Burton P. Resnick Chair in Translational Research and co-chair and professor of anatomy and structural biology; John Foxe, Ph.D., professor in the Dominick P. Purpura Department of Neuroscience and of pediatrics and director of research of the Children's Evaluation and Rehabilitation Center; Betsy Herold, M.D., professor of pediatrics, of microbiology & immunology and of obstetrics & gynecology and women's health; and Steven Libutti, M.D., vice chair and professor of surgery and associate director for clinical services of the Albert Einstein Cancer Center.

Academic Medicine published a commentary by Dean Allen M. Spiegel, M.D., that asks whether new guidelines for NIH Peer Review are improving the system or undermining it. The commentary is in response to a piece by Leslie C. Costello entitled: Perspective: Is NIH funding the "best science by the best scientists?" A Critique of the NIH R01 Research Grant Review Policies. Dr. Spiegel is the Marilyn and Stanley M. Katz Dean at Einstein and former director of the National Institute of Diabetes and Digestive and Kidney Diseases at the NIH.

ABC News features comments by Dr. Allen Spiegel, The Marilyn and Stanley M. Katz Dean, on the recent lifting of federal funding restrictions by the Obama administration on embryonic stem cell research. Dr. Spiegel was a vice chair of the NIH Stem Cell Research Task Force from 2005 to 2006 and a member of the task force from 2002-2005. In 2001, Dr. Spiegel met with President Bush to discuss the importance of human embryonic stem cell research for patients with type 1 diabetes and has testified before the House and Senate on stem cell research.